Dysregulation of TFEB activity, however, was reportedly contributed to the development of various diseases, including catabolic hyperactivity in tumors, accumulation of abnormal aggregates in neurodegenerative diseases, and aberrant host responses in inflammatory diseases. The gene discussed is TFEB; the disease is neurodegenerative disease.